Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.14-3.38%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.23% | -1.10% | -7.01% | -13.85% | -9.46% |
| Total Other Revenue | -13.69% | 13.84% | -- | 36.44% | -56.29% |
| Total Revenue | 3.88% | -0.55% | -7.01% | -11.09% | -10.84% |
| Cost of Revenue | 20.14% | 18.80% | 4.66% | 8.43% | -4.95% |
| Gross Profit | -23.46% | -27.80% | -26.18% | -51.40% | -19.26% |
| SG&A Expenses | 3.38% | -10.11% | 1.28% | 25.98% | 4.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -513.69% | 319.21% | 24.33% | -102.25% | -25.36% |
| Total Operating Expenses | 16.35% | 13.53% | 3.58% | 9.64% | -4.70% |
| Operating Income | -44.24% | -52.85% | -48.48% | -105.98% | -28.59% |
| Income Before Tax | 96.55% | -8.61% | -60.88% | -343.69% | -43.85% |
| Income Tax Expenses | -0.32% | -44.05% | -33.31% | -36.86% | -45.57% |
| Earnings from Continuing Operations | 110.96% | 3.35% | -65.27% | -474.35% | -43.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -267.44% | -374.35% | 170.67% | 103.72% | 80.33% |
| Net Income | 98.77% | -15.36% | -30.52% | -382.15% | -33.98% |
| EBIT | -44.24% | -52.85% | -48.48% | -105.98% | -28.59% |
| EBITDA | -37.83% | -45.92% | -41.50% | -90.79% | -25.16% |
| EPS Basic | 98.26% | -12.77% | -30.59% | -383.33% | -33.38% |
| Normalized Basic EPS | -21.05% | -33.48% | 7.63% | -81.32% | -8.98% |
| EPS Diluted | 98.26% | -12.77% | -30.59% | -385.78% | -33.38% |
| Normalized Diluted EPS | -21.05% | -33.48% | 7.63% | -81.32% | -8.98% |
| Average Basic Shares Outstanding | 0.24% | -3.01% | 0.03% | -0.60% | -0.82% |
| Average Diluted Shares Outstanding | 0.24% | -3.01% | 0.03% | -0.60% | -0.82% |
| Dividend Per Share | -- | -- | -- | -47.01% | -- |
| Payout Ratio | -0.94% | 7.53% | 0.27% | -1.62% | 0.61% |